KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.

Trinka E, Marson AG, Van Paesschen W, Kälviäinen R, Marovac J, Duncan B, Buyle S, Hallström Y, Hon P, Muscas GC, Newton M, Meencke HJ, Smith PE, Pohlmann-Eden B, KOMET Study Group

Open source

DOI: 10.1136/jnnp-2011-300376
Published: 2013 Oct
Container: Journal of neurology, neurosurgery, and psychiatry
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jnnp-2011-300376,
  title = {KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.},
  author = {Trinka E and Marson AG and Van Paesschen W and Kälviäinen R and Marovac J and Duncan B and Buyle S and Hallström Y and Hon P and Muscas GC and Newton M and Meencke HJ and Smith PE and Pohlmann-Eden B and KOMET Study Group},
  year = {2013},
  journal = {Journal of neurology, neurosurgery, and psychiatry},
  doi = {10.1136/jnnp-2011-300376},
  url = {https://doi.org/10.1136/jnnp-2011-300376}
}

RIS

TY  - JOUR
TI  - KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
AU  - Trinka E
AU  - Marson AG
AU  - Van Paesschen W
AU  - Kälviäinen R
AU  - Marovac J
AU  - Duncan B
AU  - Buyle S
AU  - Hallström Y
AU  - Hon P
AU  - Muscas GC
AU  - Newton M
AU  - Meencke HJ
AU  - Smith PE
AU  - Pohlmann-Eden B
AU  - KOMET Study Group
PY  - 2013
JO  - Journal of neurology, neurosurgery, and psychiatry
DO  - 10.1136/jnnp-2011-300376
UR  - https://doi.org/10.1136/jnnp-2011-300376
ER  -

APA

E, T., AG, M., W, V. P., R, K., J, M., B, D., S, B., Y, H., P, H., GC, M., M, N., HJ, M., PE, S., B, P., & Group, K. S. (2013). KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.. Journal of neurology, neurosurgery, and psychiatry. https://doi.org/10.1136/jnnp-2011-300376

Source records

pubmed · retrieved 2026-09-26T15:41:10.947Z
europe-pmc · retrieved 2026-09-26T15:41:10.933Z